Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -8.90%.However, over the last six months, we can see a stronger performance of -15.74%. Over the last 30 days, the price of ADPT has leaped by -6.45%. And in the last five days, it has surged by 11.36%.
Adaptive Biotechnologies Corporation (ADPT) currently has a stock price of $6.96. The stock saw a sharp increase in the last trading session, hitting a high of $7.015 after opening at $6.63. The lowest recorded price for the day was $6.32 before it closed at $6.54.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The market performance of Adaptive Biotechnologies Corporation has been somewhat unstable. Over the past year, the company’s stock achieved a high of $13.21 on 08/11/22, with the lowest value for the same timeframe being $5.95, recorded on 06/14/22.
52-week price history of ADPT Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Adaptive Biotechnologies Corporation’s current trading price is -47.31% away from its 52-week high, while its distance from the 52-week low is 16.88%. The stock’s price range over this timeframe has been between $5.95 and $13.21. The shares of the Healthcare sector company recorded a trading volume of approximately 1.63 million for the day, which was comparatively higher than the average daily volume of 0.85 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Adaptive Biotechnologies Corporation (ADPT) has experienced a quarterly decline of -19.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 990.06M and boasts a workforce of 790 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.29, with a change in price of -0.61. Similarly, Adaptive Biotechnologies Corporation recorded 936,924 in trading volume during the last 100 days, posting a change of -8.06%.
ADPT’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ADPT stands at 0.30. Similarly, the long-term debt-to-equity ratio is also 0.30.
ADPT Stock Stochastic Average
The raw stochastic average for Adaptive Biotechnologies Corporation over the last 50 days is presently at 33.44%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 55.87%. Further, the company’s Stochastic %K and %D values for the last 20 days were 35.51% and 23.12%, respectively.